Position in JNJ
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$3,974,122
+$175,525 QoQ
Shares Held
15,648
+0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
#1,775
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archer Investment Corp holds $22,689,953 across 14 Drug Manufacturers - General names. JNJ ranks #2 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,262 | $9,909,691 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
15,648 | $3,974,122 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,453 | $2,756,710 | |
| 4 | PFE |
Pfizer Inc
|
73,546 | $1,770,987 | |
| 5 | ABBV |
AbbVie Inc.
|
6,483 | $1,631,382 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,272 | $1,398,552 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,578 | $957,404 | |
| 8 | SNY |
Sanofi
|
4,072 | $173,711 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,974,122 | 15,648 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $3,798,597 | 15,540 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,412,191 | 16,488 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,177,913 | 17,139 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,597,972 | 17,008 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,867,041 | 17,288 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,346,748 | 16,227 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $2,629,747 | 16,227 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,286,088 | 15,641 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,332,985 | 14,748 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,270,221 | 14,484 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,244,669 | 14,412 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,367,432 | 14,303 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,042,900 | 13,180 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,327,893 | 13,178 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,125,313 | 13,010 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,309,050 | 13,008 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,297,964 | 12,966 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,215,356 | 12,950 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,107,252 | 13,048 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,134,371 | 12,956 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,934,563 | 11,771 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,378,176 | 8,757 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,297,786 | 8,717 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $874,296 | 6,217 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $946,365 | 7,217 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||